The month of August has been a great month for the exposure of the NIOV System in clinical and patient communities.
The American Journal of Respiratory Critical Care Medicine (AJRCCM) published a peer-reviewed article by Porszasz et al., regarding the clinical effectiveness of the NIOV System to reduce dyspnea (shortness of breath), while significantly prolonging exercise endurance time and improving oxygen saturation (SpO2) levels in 15 COPD patients. This clinical research paper showed that COPD patients using the NIOV System were able to exercise 245% longer as compared to breathing on regular air (17.6 mins on NIOV vs. 5.5 min on air). When compared to traditional oxygen therapy, the NIOV System improved exercise endurance by 54% (11.4 mins on O2 therapy vs. 17.6 mins on NIOV). The patients’ heart rate and respiratory rate were also markedly reduced while using the NIOV system. Patients also reported significant improvement in their dyspnea score while at rest using the NIOV System.